DJIA 18,070.40 46.34 0.26%
NASDAQ 5,016.93 11.54 0.23%
S&P 500 2,114.49 6.20 0.29%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

126.30 0.70 (0.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $126.30 0.56%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $126.07
Previous Close $125.60
Daily Range $125.46 - $129.22
52-Week Range $62.41 - $137.50
Market Cap $30.6B
P/E Ratio -40.39
Dividend (Yield) $0.00 (0.0%)
Volume 1,196,653
Average Daily Volume 1,791,805
Current FY EPS -$1.60

Sector

Healthcare

Industry

Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

Vertex Pharmaceuticals Incorporated: Waiting to Exhale

Earnings are important, but the approval of Orkambi towers over Vertex's long-term potential.

Biotech Stock Mailbag: Biotech Bull So Insanely Good It Will Make You Forget Week's Pain

Undervalued Vertex Pharmaceuticals Has One 2015 Approval In The Bag, With More To Come

The Zacks Analyst Blog Highlights: Amgen, Celladon, Kite Pharma, Pharmacyclics and Vertex Pharmaceut

The Zacks Analyst Blog Highlights: Amgen, Celladon, Kite Pharma, Pharmacyclics and Vertex Pharmaceuticals - Press Releases

Vertex Posts Wider 1Q Loss, Affirms Kalydeco Outlook - Analyst Blog

IWP, KR, NFLX, VRTX: ETF Outflow Alert

Vertex Pharmaceuticals (VRTX) Earnings Report: Q1 2015 Conference Call Transcript

Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q1 2015 Results - Earnings Call Transcript

What's Behind Vertex Pharmaceuticals Incorporated's Disappointing Q1

Another earnings miss from Vertex -- but strong growth for cystic fibrosis drug Kalydeco.

Vertex Pharmaceuticals Incorporated (VRTX) Q1 2015 Results - Earnings Call Webcast

See More VRTX News...

VRTX's Top Competitors

VRTX $126.30 (0.56%)
Current stock: VRTX
AMGN $162.11 (1.09%)
Current stock: AMGN
GILD $105.66 (0.62%)
Current stock: GILD
BIIB $386.22 (0.00%)
Current stock: BIIB